| Literature DB >> 6259914 |
E Bramm, L Binderup, E Arrigoni-Martelli.
Abstract
Daily intraperitoneal administration from day 3 to day 10 post-adjuvant of crystalline silica in doses 1.5-3.1 mg/kg per day or of amorphous silica in doses of 12.5 mg/kg per day inhibited the development of adjuvant arthritis mostly suppressing the swelling of the non-injected paw. These doses of silica did not impair the carbon clearance. Higher doses of silica (25 mg/kg per day of the crystalline form and 50 mg/kg of the amorphous form) administered from day 17 to day 24 post-adjuvant had no effect on the already established disease.Entities:
Mesh:
Substances:
Year: 1980 PMID: 6259914 DOI: 10.1007/bf01968043
Source DB: PubMed Journal: Agents Actions ISSN: 0065-4299